10x Genomics, Inc.
TXG
$22.37
-$0.25-1.11%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -43.54M | -76.32M | -84.60M | -157.04M | -182.63M |
| Total Depreciation and Amortization | 43.82M | 42.28M | 40.78M | 42.03M | 43.71M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 110.84M | 117.58M | 124.57M | 135.92M | 144.33M |
| Change in Net Operating Assets | 24.94M | 4.99M | -13.79M | 35.83M | 1.25M |
| Cash from Operations | 136.05M | 88.53M | 66.95M | 56.74M | 6.66M |
| Capital Expenditure | -5.94M | -6.87M | -10.08M | -11.38M | -12.39M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -9.27M | -8.62M | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.77M | -47.74M | -47.97M | -33.78M | -20.24M |
| Cash from Investing | -13.44M | -63.23M | -58.04M | -45.16M | -32.63M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 6.80M | 9.08M | 8.62M | 9.70M | 10.91M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 6.80M | 9.08M | 8.62M | 9.70M | 10.91M |
| Foreign Exchange rate Adjustments | 484.00K | 172.00K | 361.00K | -2.00K | -164.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 129.90M | 34.55M | 17.89M | 21.28M | -15.22M |